Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | GBA1 | P04062 | 5/20 | 0.51 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | GJB2 | P29033 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | CETP | P11597 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10775003 | 1.00 | TNF (0.58) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL14747649 | 0.94 | TNF (0.51) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL16414481 | 0.94 | TNF (0.51) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL25414516 | 0.91 | MAPK1 (0.60) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL25415166 | 0.91 | MAPK1 (0.60) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL25415432 | 0.91 | MAPK1 (0.60) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL15499729 | 0.90 | TNF (0.56) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL17304977 | 0.90 | TNF (0.56) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL16421742 | 0.90 | TNF (0.56) | TNFMAPK1GBA1SLC2A1GJB2 | |
| SCHEMBL13885908 | 0.90 | TNF (0.56) | TNFMAPK1GBA1SLC2A1GJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233849-A2 | MAPT siRNA AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2025-11-13 | — | — | WO | disclosed |
| EP-4493691-A2 | MAPT SIRNA AND USES THEREOF | JANSSEN Pharmaceutica NV (BE) | 2025-01-22 | — | — | EP | disclosed |
| WO-2023175536-A1 | LIPID MONOMERS FOR THERAPEUTIC DELIVERY OF RNA | JANSSEN BIOTECH, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023175091-A2 | MAPT siRNA AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2023-09-21 | — | — | WO | disclosed |